This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Immune Response

  • Strategy for Fighting Persistent Bacterial Infections is Discovered
    Researchers at National Jewish Health have discovered a promising strategy for destroying the molecular scaffolding that can make Pseudomonas bacterial infections extremely difficult to treat in cystic fibrosis patients, wearers of contact lenses, and burn victims. Jerry ...More
    March 23, 2009 Posted in News
  • Investigating the Link Between Flu and Pneumonia
    A joint venture from researchers from the Helmholtz-Centre for Infection Research (HZI) in Braunschweig, the Otto-von-Guericke-University in Magdeburg, and the Karolinska institute in Sweden have taken an in-depth look at the connection between flu infection and pneumonia. ...More
    March 17, 2009 Posted in News
  • Goodbye Needle, Hello Smoothie for Disease Protection
    Instead of a dreaded injection with a needle, someday getting vaccinated against disease may be as pleasant as drinking a yogurt smoothie. A researcher from the Northwestern University Feinberg School of Medicine has developed a new oral vaccine using probiotics, the ...More
    March 17, 2009 Posted in News
  • TB Breakthrough Could Lead to Stronger Vaccine
    A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at the University of Texas Health Science Center at Houston in Nature ...More
    March 3, 2009 Posted in News
  • New Discovery Gives TB Vaccine a Shot in the Arm
    A new article appearing in the March 2009 issue of the Journal of Leukocyte Biology may lead to improvements in the efficacy of the current tuberculosis vaccine. Specifically, a team of Italian researchers discovered a new role for type I interferon, in which it improves ...More
    February 26, 2009 Posted in News
  • Vaccine Research Targets HIV in the Slower, Early Stage of Infection
    New research at OregonHealth & ScienceUniversity's Vaccine and Gene Therapy Institute suggests vaccines that specifically target HIV in the initial stages of infection --  before it becomes a rapidly replicating, system-wide infection -- may be a successful ...More
    February 17, 2009 Posted in News
  • When Acute Hepatitis Develops Into Chronic Hepatitis
    Researchers at the Helmholtz Center in Braunschweig, Germany are demonstrating how the immune system reacts to a hepatitis B infection. To achieve this, Carlos A. Guzmán, head of the vaccinology and applied microbiology working group, and Robert Geffers, head of the ...More
    February 17, 2009 Posted in News
  • Good Bacteria Can be Vehicle for Oral Vaccine Against Anthrax
    Researchers at North CarolinaStateUniversity have discovered that the good bacteria found in dairy products and linked to positive health benefits in the human body might also be an effective vehicle for an oral vaccine that can provide immunity to anthrax exposure. The ...More
    February 16, 2009 Posted in News
  • Chronic Infection May Add to Deaths
    Worldwide, nearly 2 million people per year die from diarrhea, the vast majority of them in poor countries in Africa and Asia. The disease accounts for 18 percent of all deaths among children — and yet is almost always preventable with proper treatment. Now, new ...More
    February 12, 2009 Posted in News
  • Flu Damage Includes Fluid Build-up in the Lungs
    By Emily CaldwellIn a fight against respiratory infections, the body typically produces a little fluid to help the lungs generate a productive cough. But new research suggests that the influenza virus can tip the balance toward too much fluid in the lungs, interfering with ...More
    February 10, 2009 Posted in News, PPE & Standard Precautions